lists of glp.1 List approved and pending GLP-1 medications List of current GLP-1 and

dosage should be reduced in patients with renal impairment no dosage adjustment required for mild to moderate hepatic insufficiency Side Effects: upper respiratory infection pancreatitis - there have been post-marketing reports of acute pancreatitis

Pfizer, Eli Lilly and Company, Amgen, Novo Nordisk, Carmot Therapeutics, Structure Therapeutics, Metsera, and Zealand Pharma

Our timing guide for semaglutide covers this in more detail

However, in phase 3a trials, mean baseline Patient Health Questionnaire-9 (PHQ-9) scores for liraglutide vs placebo improved at the treatment end

Weighing In on Obesity and Psoriatic Arthritis Time to Move Beyond Association to Robust Randomised Trials